Cherubism: best clinical practice
Open Access
- 24 May 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 7 (S1), S6
- https://doi.org/10.1186/1750-1172-7-s1-s6
Abstract
Cherubism is a skeletal dysplasia characterized by bilateral and symmetric fibro-osseous lesions limited to the mandible and maxilla. In most patients, cherubism is due to dominant mutations in the SH3BP2 gene on chromosome 4p16.3. Affected children appear normal at birth. Swelling of the jaws usually appears between 2 and 7 years of age, after which, lesions proliferate and increase in size until puberty. The lesions subsequently begin to regress, fill with bone and remodel until age 30, when they are frequently not detectable. Fibro-osseous lesions, including those in cherubism have been classified as quiescent, non-aggressive and aggressive on the basis of clinical behavior and radiographic findings. Quiescent cherubic lesions are usually seen in older patients and do not demonstrate progressive growth. Non-aggressive lesions are most frequently present in teenagers. Lesions in the aggressive form of cherubism occur in young children and are large, rapidly growing and may cause tooth displacement, root resorption, thinning and perforation of cortical bone. Because cherubism is usually self-limiting, operative treatment may not be necessary. Longitudinal observation and follow-up is the initial management in most cases. Surgical intervention with curettage, contouring or resection may be indicated for functional or aesthetic reasons. Surgical procedures are usually performed when the disease becomes quiescent. Aggressive lesions that cause severe functional problems such as airway obstruction justify early surgical intervention.Keywords
This publication has 99 references indexed in Scilit:
- The role of SH3BP2 in the pathophysiology of cherubismOrphanet Journal of Rare Diseases, 2012
- Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter – Case ReportMolecular Syndromology, 2010
- Noonan Syndrome: Clinical Aspects and Molecular PathogenesisMolecular Syndromology, 2010
- Cherubism Combined with Epilepsy, Mental Retardation and Gingival Fibromatosis (Ramon Syndrome): A Case ReportHead and Neck Pathology, 2009
- SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesionsEuropean Journal of Human Genetics, 2009
- NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubismJCI Insight, 2008
- TNFα blockade in human diseases: Mechanisms and future directionsClinical Immunology, 2008
- TNFα blockade in human diseases: An overview of efficacy and safetyClinical Immunology, 2008
- The 3BP2 Adapter Protein Is Required for Optimal B-Cell Activation and Thymus-Independent Type 2 Humoral ResponseMolecular and Cellular Biology, 2007
- 3BP2 Deficiency Impairs the Response of B Cells, but Not T Cells, to Antigen Receptor LigationMolecular and Cellular Biology, 2006